George Soros Biomarin Pharmaceutical Inc Transaction History

Soros Fund Management LLC

  • $4.68 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $11,387 - $14,109
153 Added 0.1%
156,053 $12.8 Million
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $13.1 Million - $15.4 Million
155,900 New
155,900 $13.6 Million
Q3 2017

Nov 14, 2017
SELL
$80.6 - $94.95 $201,500 - $237,375
-2,500 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
2,500
2,500 $227,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track George Soros's Portfolio

Track George Soros Portfolio

Follow George Soros (Soros Fund Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soros Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soros Fund Management LLC and George Soros with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email